b.vestergaard
TL2 · Genoa
Contributes reviews on supplier material. Based in Genoa.
Joined 26 May 2025 · last posted 2d
82 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #27 · Compounds › Oral incretins · 26 Jul 2026 · 8 likes If you are new and reading this thread for the answer to PIONEER 6 cardiovascular safety: the answer is conditional, the conditions are in the third reply, and the rest…
-
Common supplements people ask about, assessed one at a time Replied, post #91 · Practice › Interactions · 24 Jul 2026 · 0 likes Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one. One…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #23 · Analytics › Mass spectrometry · 22 Jul 2026 · 2 likes Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #98 · Evidence › Journal club · 22 Jul 2026 · 4 likes On SUSTAIN 6: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #67 · Start Here › Welcome · 21 Jul 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Seven-day rolling means and why weekly readings mislead Replied, post #73 · Outcomes › Progress reports · 21 Jul 2026 · 16 likes Adding the measurement that post #72 says would settle it. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing…
-
Pages past their review date, listed — does this still hold? Replied, post #57 · Meta › Wiki maintenance · 17 Jul 2026 · 25 likes On post #55 — agreed on the reasoning, with one qualification. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned.…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #84 · Wellbeing › Sleep · 13 Jul 2026 · 6 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #20 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 1 like Understood, and I withdraw the assumption I opened with.
-
Submitting a sample: the process end to end Replied, post #65 · Sourcing › Independent verification · 7 Jul 2026 · 13 likes Post #64 answers the question as asked. The question underneath it is different. Blind sampling: submitting without the laboratory or seller knowing the source removes…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #28 · Compounds › Semaglutide · 7 Jul 2026 · 33 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #31 · Practice › Dosing & titration · 2 Jul 2026 · 16 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #88 · Start Here › How to Ask · 1 Jul 2026 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
Athletes in weight-category sports: a different risk calculus Replied, post #4 · Clinical › Special populations · 26 Jun 2026 · 6 likes Post #3 is the version of this I will quote in future. One addition. The most useful contribution here is usually a citation to whichever published document comes…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #7 · Devices › Syringes & needles · 12 Jun 2026 · 1 like Where I have landed on Reading a syringe, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #98 · Sourcing › Logistics · 11 Jun 2026 · 1 like Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
-
A checklist for reading a certificate in under two minutes Replied, post #32 · Analytics › COA interpretation · 2 Jun 2026 · 18 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #49 · Evidence › Journal club · 24 May 2026 · 17 likes Post #46 is the version of this I will quote in future. One addition. I would call the community position on SURMOUNT-1 likely rather than established, and I would be…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #6 · Compounds › Retatrutide · 18 May 2026 · 29 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #70 · Clinical › Bloodwork · 17 May 2026 · 5 likes Ask what decision the result would change before ordering it. A test whose result changes nothing is a test that generates worry rather than information.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #30 · Analytics › Home & field testing · 17 May 2026 · 2 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #21 · Compounds › Repair & healing peptides · 5 May 2026 · 0 likes Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #31 · Practice › Administration · 23 Apr 2026 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Careful with the language on completing a dose. "Not detected" and "not present"…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #10 · Evidence › Study critique · 22 Apr 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #6 · Evidence › Journal club · 20 Apr 2026 · 4 likes Summarising the STEP 1 thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #113 · Clinical › Special populations · 17 Apr 2026 · 14 likes Post #112 answers the question as asked. The question underneath it is different. Nothing in this subcategory is medical advice and the questions asked here are…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #70 · Analytics › Mass spectrometry · 10 Apr 2026 · 2 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Splitting an overlong document into two Replied, post #12 · Documentation › Wiki requests · 9 Apr 2026 · 30 likes Narrowing post #10, because the general version has more than one answer. Splitting an overlong document would be much easier to settle if anyone reported the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #17 · Meta › Site feedback · 8 Apr 2026 · 14 likes Confirming post #14 from a second method, which matters more than confirming it from a second person. What I want from this timeline thread is the list of things that…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #68 · Practice › Administration · 7 Apr 2026 · 3 likes Adding the measurement that post #65 says would settle it. Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and it is…
-
The "under review" status pill and when a moderator applies it Replied, post #33 · Evidence › Preprints · 23 Mar 2026 · 2 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I would call that likely rather than established.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #5 · marked as the solution · Analytics › Mass spectrometry · 11 Feb 2026 · 12 likes I read the opening post twice before replying, because I had assumed the opposite. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Constipation management, with a dietitian's contribution Replied, post #20 · Practice › Side effects · 17 Jan 2026 · 0 likes Building on post #17 rather than restating it. A note on how constipation management gets discussed rather than on constipation management itself: the confident posts…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #7 · Compounds › Semaglutide · 14 Jan 2026 · 0 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. Cardiovascular data in people without diabetes is the specific contribution of…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #12 · Pharmacology › Pharmacokinetics · 10 Jan 2026 · 5 likes Picking up post #9: that is the part I would want checked first. The question underneath Washout is usually "how would I tell?" rather than "what is true?", and that…
-
Reading an interaction checker output critically Replied, post #80 · Practice › Interactions · 31 Dec 2025 · 16 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here. Reading it again,…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #74 · Compounds › Tirzepatide · 10 Dec 2025 · 23 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #8 · Compounds › Tirzepatide · 6 Dec 2025 · 17 likes This settles it for me, at least until somebody posts a reason it should not.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #61 · Compounds › Semaglutide · 4 Dec 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
Guidelines revision: what changed and why — one year on Replied, post #41 · Meta › Announcements · 30 Nov 2025 · 6 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #78 · Practice › Reconstitution · 26 Nov 2025 · 12 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #13 · Sourcing › Regulatory · 3 Nov 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
EMA product information as a primary source Replied, post #6 · Regional › European Union · 26 Oct 2025 · 2 likes On EMA product information I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
About the Statistics category Replied, post #3 · Research Methods › Statistics · 22 Oct 2025 · 10 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Payment method and the leverage it gives you, ranked Replied, post #69 · Sourcing › Payments · 24 Sep 2025 · 2 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge. I would want to…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #14 · Analytics › Home & field testing · 19 Sep 2025 · 3 likes Post #11 answers the question as asked. The question underneath it is different. Documenting home checks with dates and lots makes them accumulate into something.…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #37 · Compounds › Tirzepatide · 30 Aug 2025 · 0 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. Half-life difference: tirzepatide is about 5 days versus…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #38 · Evidence › Journal club · 22 Aug 2025 · 0 likes Orforglipron phase 2 is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #12 · Devices › Pens & autoinjectors · 28 Jul 2025 · 0 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2025 · 0 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Started this topic · Clinical › Special populations · 14 Jul 2025 · 1 like Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. A narrow…
-
Sequence verification for an obscure compound: how it is done Replied, post #90 · Compounds › Other compounds · 12 Jul 2025 · 17 likes Fragment compounds — where the material is part of a larger natural protein — should be identified by sequence rather than by name, because the naming in this space is…
-
Tracking that stops updating and then resumes Replied, post #9 · Sourcing › Logistics · 10 Jul 2025 · 0 likes Tracking accuracy at each hop is a reasonable proxy for how much attention the shipment is getting, and it costs nothing to note.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #8 · Practice › Reconstitution · 5 Jun 2025 · 9 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Half-life, steady state, and accumulation worked through Replied, post #37 · Pharmacology › Pharmacokinetics · 29 May 2025 · 10 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Pregnancy as an absolute contraindication Replied, post #78 · Safety › Contraindications · 20 May 2025 · 5 likes Prior hypersensitivity to the product or its excipients is a contraindication that people forget applies to the excipients too. For what it is worth, the same held on…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #31 · Evidence › Journal club · 13 May 2025 · 0 likes The strongest argument against my own position on SURMOUNT-4 and continuation versus withdrawal, stated as well as I can state it, since nobody else has yet.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #97 · Access › Pricing · 12 May 2025 · 0 likes The arithmetic in post #94 is right; the assumption feeding it is the part to check. Nothing here is financial advice and none of it is a route to a transaction.
-
Carryover and the ghost peak from last week's standard Replied, post #82 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 0 likes Post #80 and I disagree about the size of the effect, not about the direction. A relative retention time against a known peak travels much better than an absolute one,…
-
Carryover and the ghost peak from last week's standard Replied, post #61 · Analytics › HPLC & UHPLC · 9 Apr 2025 · 0 likes Post #60 is right about the mechanism and I think understates the practical bit. Purity by chromatography answers "what proportion of what I detected is the intended…
-
Ipamorelin selectivity claims and where they came from Replied, post #25 · Compounds › Secretagogues & GH axis · 1 Apr 2025 · 0 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #19 · Evidence › Trials · 26 Mar 2025 · 6 likes A definition problem is doing most of the work in this Open-label extensions discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #48 · Compounds › Semaglutide · 22 Mar 2025 · 12 likes On SELECT I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get…
-
Validating a method you did not develop — does this still hold? Replied, post #80 · Analytics › Method validation · 6 Mar 2025 · 7 likes Where I part company with post #77, and it is a narrow parting. The failure mode on Validating a method is boring rather than dramatic. It is almost always the step…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2025 · 11 likes Building on post #73 rather than restating it. What I would tell a new member reading about amylin analogue mechanism for the first time: the confident posts are not…
-
Checking someone else's arithmetic: a worked example thread Replied, post #26 · Practice › Reconstitution · 2 Mar 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Validating a method you did not develop — does this still hold? Replied, post #32 · Analytics › Method validation · 22 Feb 2025 · 0 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
When to suspect the method rather than the sample Replied, post #85 · Analytics › Method validation · 20 Feb 2025 · 0 likes Sample stability during analysis is part of validation and is routinely ignored. A preparation that degrades in the autosampler over eight hours produces a…
-
Consistent declarations and why they matter more than clever ones Replied, post #48 · Sourcing › Logistics · 18 Feb 2025 · 10 likes This follows post #46 rather than contradicting it. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #35 · Practice › Reconstitution · 17 Feb 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #50 · Devices › Cold chain · 11 Feb 2025 · 9 likes What I want from this Domestic fridge temperature mapping thread is the list of things that would need to be true for the claim to hold. If we can write that list, we…
-
What changed in 2026, by region Replied, post #109 · Access › International · 30 Jan 2025 · 1 like Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #6 · Compounds › Tirzepatide · 23 Jan 2025 · 0 likes On GIP component of tirzepatide, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #10 · Devices › Pens & autoinjectors · 19 Jan 2025 · 5 likes Travel with a pen raises a cold-chain question and a documentation question. The second is the one people forget until an airport. I would want to see it done twice…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #91 · Access › Insurance & coverage · 28 Dec 2024 · 3 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #7 · Compounds › Oral incretins · 25 Dec 2024 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
EMA product information as a primary source — does this still hold? Replied, post #41 · Regional › European Union · 16 Nov 2024 · 0 likes I would be cautious about generalising from the EMA product information example above. It is a good example. It is one example.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #89 · Compounds › Other compounds · 2 Nov 2024 · 0 likes The number people quote for Melanocortin agonists is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #8 · Wellbeing › Mental health · 28 Sep 2024 · 0 likes The bit of Food noise that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Pen wastage and its effect on real cost Replied, post #19 · Access › Pricing · 26 Aug 2024 · 0 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
-
Blind submission and why it changes minds Replied, post #28 · Sourcing › Independent verification · 3 Aug 2024 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #15 · Practice › Dosing & titration · 7 Jun 2024 · 0 likes I read post #11 twice before replying, because I had assumed the opposite. Concentration and dose get conflated constantly in this subcategory. Changing how much…